Pharmacokinetics and Safety of RV521 Formulations

Status:
Completed

Trial end date:
2019-09-09

Target enrollment:

Participant gender:

The main aims of the study are to assess the pharmacokinetics and safety of single doses of RV521 administered as two different formulations

Phase 1

ReViral Ltd